Chimerix, Inc.
(NASDAQ : CMRX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -0.08%170.970.7%$968.43m
ABBVAbbVie, Inc. 0.25%138.381.9%$830.03m
PFEPfizer Inc. -0.33%49.110.9%$822.41m
LLYEli Lilly & Co. -1.13%297.931.1%$737.80m
MRKMerck & Co., Inc. -0.32%87.130.7%$737.52m
BMYBristol-Myers Squibb Co. 0.11%72.201.0%$650.54m
SIGASIGA Technologies, Inc. -0.21%23.250.0%$411.97m
AZNAstraZeneca Plc -0.47%65.721.0%$379.68m
ALNYAlnylam Pharmaceuticals, Inc. 1.47%221.798.1%$244.81m
GSKGSK Plc 0.00%40.570.3%$217.86m
HZNPHorizon Therapeutics Plc 1.15%70.405.4%$200.06m
SGENSeagen Inc. 2.52%180.245.7%$193.50m
NVSNovartis AG 0.47%85.970.2%$174.19m
RGENRepligen Corp. 0.84%248.346.7%$157.06m
NVONovo Nordisk A/S -0.71%102.470.1%$151.82m

Company Profile

Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded by George R. Painter, III and Timothy Wollaeger in April 2000 and is headquartered in Durham, NC.